Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series.

ABSTRACT:

Objective

Evidence strongly supports the use of mifepristone-misoprostol combination treatment for early pregnancy loss (EPL) among pregnancies conceived without assisted reproductive technologies. No literature exists, however, regarding the efficacy of this treatment in the medical management of EPL among pregnancies after in vitro fertilization and embryo transfer (IVF-ET). These patients differ as some use exogenous hormonal supplementation to provide pregnancy support. Thus, the management for EPL may differ between unassisted conceptions and those after ET. Mifepristone, a progesterone receptor antagonist, may demonstrate an altered treatment effect when used with misoprostol to manage EPL in assisted reproductive technologie-conceived pregnancies.

Objective

To describ

SUBMITTER: Esposito L 

PROVIDER: S-EPMC10028465 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature